Overexpression of ABCB4 contributes to acquired doxorubicin resistance in breast cancer cells in vitro
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of ABCB4 contributes to acquired doxorubicin resistance in breast cancer cells in vitro
Authors
Keywords
ABCB4, Doxorubicin, Acquired resistance, Breast cancer cells
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 82, Issue 2, Pages 199-210
Publisher
Springer Nature
Online
2018-05-18
DOI
10.1007/s00280-018-3603-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phthalocyanine induced phototherapy coupled with Doxorubicin; a promising novel treatment for breast cancer
- (2017) Eric Chekwube Aniogo et al. Expert Review of Anticancer Therapy
- ABC transporters in megakaryopoiesis and platelet activity
- (2017) Wei Wang et al. THROMBOSIS RESEARCH
- Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients
- (2017) Lourdes Hontecillas-Prieto et al. Oncotarget
- ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview
- (2016) Elena Arrigoni et al. Expert Opinion on Drug Metabolism & Toxicology
- Characterization of acquired paclitaxel resistance of breast cancer cells and involvement of ABC transporters
- (2016) Vlasta Němcová-Fürstová et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro
- (2015) Daniela Cihalova et al. BIOCHEMICAL PHARMACOLOGY
- Meloxicam increases intracellular accumulation of doxorubicin via downregulation of multidrug resistance-associated protein 1 (MRP1) in A549 cells
- (2015) S.F. Chen et al. GENETICS AND MOLECULAR RESEARCH
- Comparative Localization and Functional Activity of the Main Hepatobiliary Transporters in HepaRG Cells and Primary Human Hepatocytes
- (2015) Pamela Bachour-El Azzi et al. TOXICOLOGICAL SCIENCES
- ABCB4: Insights from pathobiology into therapy
- (2014) Thomas Falguières et al. Clinics and Research in Hepatology and Gastroenterology
- ABCB4 is frequently epigenetically silenced in human cancers and inhibits tumor growth
- (2014) Steffen Kiehl et al. Scientific Reports
- Expression of MDR1 and MDR3 gene products in paclitaxel-, doxorubicin- and vincristine-resistant cell lines
- (2013) Radosław Januchowski et al. BIOMEDICINE & PHARMACOTHERAPY
- Increased Expression of P-Glycoprotein and Doxorubicin Chemoresistance of Metastatic Breast Cancer Is Regulated by miR-298
- (2012) Lili Bao et al. AMERICAN JOURNAL OF PATHOLOGY
- Elevated level of lysine 9-acetylated histone H3 at the MDR1 promoter in multidrug-resistant cells
- (2012) Monika Toth et al. CANCER SCIENCE
- Expression of multidrug resistance-associated proteins in paediatric soft tissue sarcomas before and after chemotherapy
- (2012) Doriana Fruci INTERNATIONAL JOURNAL OF ONCOLOGY
- Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma
- (2011) M Yamasaki et al. BRITISH JOURNAL OF CANCER
- Pharmacogenetics of Target Genes Across Doxorubicin Disposition Pathway: A Review
- (2010) Suman Lal et al. CURRENT DRUG METABOLISM
- Canine ABCB4: Tissue expression and cDNA structure
- (2010) Erick S. Spencer et al. RESEARCH IN VETERINARY SCIENCE
- Histone Modifications at the ABCG2 Promoter following Treatment with Histone Deacetylase Inhibitor Mirror Those in Multidrug-Resistant Cells
- (2008) K. K.W. To et al. MOLECULAR CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now